Lv1
100 积分 2022-08-22 加入
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
1个月前
已完结
淋巴瘤PET/CT及PET/MR显像临床应用指南(2025版)
2个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
3个月前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
10个月前
已完结
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
1年前
已完结
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
1年前
已完结
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
1年前
已完结
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
1年前
已完结
International uniform response criteria for multiple myeloma
1年前
已完结
皖公网安备34019202002308
